Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning.

Item

http://www.wikidata.org/entity/Q41663868

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Acute GVHD prophylaxis with st ...... rabine/melphalan conditioning.

@en

type

Item

label

Acute GVHD prophylaxis with st ...... rabine/melphalan conditioning.

@en

prefLabel

Acute GVHD prophylaxis with st ...... rabine/melphalan conditioning.

@en

P1476

Acute GVHD prophylaxis with st ...... rabine/melphalan conditioning.

@en

P2093

G L Chen

http://www.w3.org/2001/XMLSchema#string

H Liu

http://www.w3.org/2001/XMLSchema#string

M Ross

http://www.w3.org/2001/XMLSchema#string

P L McCarthy

http://www.w3.org/2001/XMLSchema#string

S Abrams

http://www.w3.org/2001/XMLSchema#string

T Hahn

http://www.w3.org/2001/XMLSchema#string

Y Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of human type I and type II IMP dehydrogenases

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens.

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

Risk factors for acute GVHD and survival after hematopoietic cell transplantation

Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.

One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.

Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.

Comparison of Tacrolimus and Sirolimus (Tac/Sir) versus Tacrolimus, Sirolimus, and mini-methotrexate (Tac/Sir/MTX) as acute graft-versus-host disease prophylaxis after reduced-intensity conditioning allogeneic peripheral blood stem cell transplantat

P2888

bmt.2013.167

P304

248-253

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2013.167

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1021279028

http://www.w3.org/2001/XMLSchema#string

P698

24162612

http://www.w3.org/2001/XMLSchema#string

P932

5621044

http://www.w3.org/2001/XMLSchema#string